Van Driessche et al10.1073/pnas.0705996104XXYYYYY103.
Table 2. RT-PCR of microarray data from wild-type cells
|
Gene name |
DDB no. |
Fold change* |
P value† |
|
|
0 mM cisplatin |
300 mM cisplatin |
|||
|
abcB1 |
DDB0201666 |
0.77 ± 0.12 |
0.29 ± 0.11 |
0.0007 |
|
abcF4 |
DDB0191119 |
0.89 ± 0.07 |
0.38 ± 0.07 |
0.0323 |
|
abcG10 |
DDB0214895 |
0.71 ± 0.16 |
0.20 ± 0.02 |
0.0800 |
|
abcG21 |
DDB0191239 |
0.88 ± 0.07 |
0.35 ± 0.01 |
0.0142 |
|
alyB |
DDB0231278 |
0.83 ± 0.12 |
2.98 ± 1.08 |
0.1760 |
|
amtA |
DDB0185017 |
0.66 ± 0.18 |
4.91 ± 2.19 |
0.1948 |
|
atg8 |
DDB0191413 |
0.63 ± 0.21 |
0.13 ± 0.01 |
0.1384 |
|
bzpH |
DDB0220095 |
0.69 ± 0.16 |
0.18 ± 0.05 |
0.0444 |
|
cycB |
DDB0185035 |
0.72 ± 0.14 |
6.68 ± 1.19 |
0.0454 |
|
cprE |
DDB0185092 |
0.83 ± 0.09 |
2.41 ± 0.59 |
0.0901 |
|
dnmA |
DDB0187754 |
0.81 ± 0.11 |
0.29 ± 0.02 |
0.0585 |
|
repD |
DDB0191272 |
0.81 ± 0.10 |
0.17 ± 0.02 |
0.0285 |
|
ubpA |
DDB0231492 |
0.57 ± 0.22 |
0.09 ± 0.03 |
0.1964 |
*The data are averages and standard errors of three independent experiments, each done in triplicate.
†From a two-tailed t test.
Table 3. RT-PCR of microarray data from wild-type and mutant strains
|
Gene name |
DDB no. |
Fold change* |
P value† |
||||||
|
AX4 |
sglA- |
sgkAOE |
|||||||
|
0 mM cisplatin |
300 mM cisplatin |
0 mM cisplatin |
300 mM cisplatin |
0 mM cisplatin |
300 mM cisplatin |
Genotype |
Treatment |
||
|
abcF4 |
DDB0191119 |
0.64 ± 0.10 |
0.10 ± 0.02 |
1.04 ± 0.40 |
0.62 ± 0.09 |
0.56 ± 0.06 |
1.04 ± 0.29 |
0.094 |
0.395 |
|
aprA |
DDB0231036 |
0.51 ± 0.12 |
1.49 ± 0.25 |
0.09 ± 0.03 |
0.25 ± 0.07 |
0.10 ± 0.01 |
0.34 ± 0.05 |
3.8E-07 |
2.0E-04 |
|
N/A |
DDB0188863 |
0.28 ± 0.15 |
6.84 ± 1.56 |
0.02 ± 0.00 |
0.53 ± 0.18 |
0.02 ± 0.00 |
0.10 ± 0.02 |
0.001 |
0.003 |
|
ddiA |
DDB0230141 |
0.38 ± 0.13 |
3.84 ± 1.20 |
0.02 ± 0.00 |
2.64 ± 1.35 |
0.03 ± 0.01 |
0.24 ± 0.06 |
0.031 |
0.001 |
|
expl3 |
DDB0169422 |
0.74 ± 0.08 |
0.40 ± 0.08 |
0.35 ± 0.06 |
0.14 ± 0.03 |
0.00 ± 0.00 |
0.00 ± 0.00 |
7.2E-10 |
0.001 |
|
guaA |
DDB0215334 |
0.94 ± 0.06 |
4.70 ± 0.50 |
0.22 ± 0.03 |
0.41 ± 0.07 |
0.24 ± 0.08 |
0.80 ± 0.13 |
2.6E-05 |
4.5E-04 |
|
idhB |
DDB0231294 |
0.62 ± 0.08 |
0.49 ± 0.06 |
2.89 ± 0.66 |
0.18 ± 0.03 |
0.61 ± 0.10 |
0.55 ± 0.28 |
0.087 |
0.011 |
|
N/A |
DDB0204602 |
0.52 ± 0.10 |
0.10 ± 0.02 |
172 ± 170 |
1.82 ± 0.53 |
0.10 ± 0.02 |
119 ± 118 |
0.602 |
0.811 |
N/A, no name assigned to this gene.
*The data are averages and standard errors of two independent experiments, each done in triplicate.
†From an ANOVA, considering genotype, treatment, and replication as parameters. Genotype and treatment are shown; the P values for treatments were all >0.05 (data not shown), indicating that biological and technical replications did not contribute significantly to the fold change.
Table 4. Distribution of cisplatin response genes in transcriptional modes
|
Mode* |
Cisplatin response genes |
Total genes in mode |
Expected† |
c2 |
P value |
|
1 |
41 |
191 |
18.437 |
27.613 |
1.48E-07 |
|
2 |
6 |
44 |
4.247 |
0.723 |
0.395 |
|
3 |
86 |
664 |
64.094 |
7.487 |
0.006 |
|
4 |
26 |
298 |
28.765 |
0.266 |
0.606 |
|
5 |
57 |
461 |
44.499 |
3.512 |
0.061 |
|
6 |
36 |
492 |
47.492 |
2.781 |
0.095 |
|
7 |
20 |
199 |
19.209 |
0.033 |
0.857 |
|
8 |
54 |
553 |
53.380 |
0.007 |
0.932 |
|
9 |
1 |
22 |
2.124 |
0.595 |
0.441 |
|
10 |
2 |
11 |
1.062 |
0.829 |
0.363 |
|
11 |
4 |
66 |
6.371 |
0.882 |
0.348 |
|
12 |
19 |
201 |
19.402 |
0.008 |
0.927 |
|
13 |
6 |
123 |
11.873 |
2.905 |
0.088 |
|
14 |
0 |
28 |
2.703 |
2.703 |
0.100 |
|
15 |
43 |
553 |
53.380 |
2.018 |
0.155 |
|
16 |
2 |
20 |
1.931 |
0.002 |
0.960 |
|
17 |
64 |
912 |
88.033 |
6.561 |
0.010 |
|
Total |
467 |
4,838 |
|
|
|
*Modes are defined as groups of coregulated genes that are developmentally coregulated in wild type and in several mutant strains under various conditions as described in ref. 1.
†467 ´ (total genes in mode)/4838.
1. Booth EO, Van Driessche N, Zhuchenko O, Kuspa A, Shaulsky G (2005) Bioinformatics 21:4371-4377.